Skip to content

Nasal Packing After Turbinoplasty

Nasal Packing After Turbinoplasty, Is it Worthwhile? A Prospective Study ?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07663929
Enrollment
135
Registered
2026-06-23
Start date
2026-01-01
Completion date
2026-06-03
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal Packing

Brief summary

This study aims to to compare postoperative pain, patient comfort, and hemostatic safety among four non-absorbable nasal packing techniques following microdebrider-assisted inferior turbinoplasty (MAIT) and to identify the most effective low-cost packing option.

Interventions

PROCEDUREStandard bilateral Merocel® nasal tampons packing after Microdebrider-assisted inferior turbinoplasty

Standard bilateral Merocel® nasal tampons (Medtronic, USA) were inserted in their dry compressed form. Prior to insertion, each tampon was trimmed according to the dimensions of the patient's nasal cavity. Following contact with nasal secretions, the Merocel expanded to provide gentle and uniform pressure over the operative site.

PROCEDUREA Merocel® tampon was enclosed within the finger portion of a sterile powder-free latex surgical glove after Microdebrider-assisted inferior turbinoplasty

A Merocel® tampon was enclosed within the finger portion of a sterile powder-free latex surgical glove. The glove finger was then partially stripped to expose portions of the Merocel surface while retaining a thin latex interface, thereby preventing the glove from acting as a complete barrier and allowing contact between the Merocel and surrounding nasal secretions. This modification preserved the expansion and absorptive properties of the Merocel while creating a smoother, less adherent outer surface.

PROCEDUREMerocel® tampons were coated with a thin uniform layer of topical broad-spectrum antibiotic ointment after microdebrider-assisted inferior turbinoplasty

Merocel® tampons were coated with a thin uniform layer of topical broad-spectrum antibiotic ointment, such as fusidic acid 2% plus corticosteroids, prior to bilateral insertion. This modification was intended to provide localized antimicrobial coverage while preserving the hemostatic effect of the packing material.

PROCEDUREterile ribbon gauze impregnated with white petroleum jelly (paraffin) after microdebrider-assisted inferior turbinoplasty

Sterile ribbon gauze impregnated with white petroleum jelly (paraffin) was loosely packed into each nasal cavity in a layered accordion-like fashion, beginning at the nasal floor and progressing posteriorly. Packing density was standardized to achieve adequate hemostasis while avoiding excessive pressure on the nasal mucosa.

Sponsors

Kafrelsheikh University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18-65 years. * Chronic bilateral nasal obstruction secondary to inferior turbinate hypertrophy. * Failure of conservative medical management for at least 3 months, including intranasal corticosteroids and oral antihistamines. * Positive decongestion test showing ≥30% improvement in anterior nasal cavity volume (V2-5 cm) on acoustic rhinometry after topical xylometazoline 0.5%, confirming predominantly mucosal rather than bony hypertrophy. * Inferior turbinate hypertrophy grade 3 or 4 according to the Camacho classification system.

Exclusion criteria

* Significant nasal septal deviation affecting the nasal valve region. * Internal or external nasal valve collapse or stenosis. * Chronic rhinosinusitis with or without nasal polyposis. * Previous nasal or paranasal sinus surgery. * Coagulopathy or current anticoagulant therapy. * Uncontrolled systemic disease. * Pregnancy. * Active smoking. * Known allergic sensitization to any component of the nasal packing materials.

Design outcomes

Primary

MeasureTime frameDescription
Pain intensityWe assesed pain during first 48 hours postoperative.1.Pain intensity Assessed using the Visual Analogue Scale (VAS) (0 = no pain, 10 = worst imaginable pain)
Bleeding after packing removal Assessed using a 4-point grading scaleWe assesed bleeding immediately after nasal packing removalGrade 0 = no bleeding Grade 1 = oozing Grade 2 = continuous bleeding Grade 3 = bleeding requiring intervention or control in the operating room

Secondary

MeasureTime frameDescription
Nasal fullness/pressure sensationWe assesed it during first 48 hours postoperative.Nasal fullness/pressure sensation Assessed using the Visual Analogue Scale (VAS; 0-10)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026